Clinical Trials Directory

The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy

Blood Ropivacaine Concentrations Following Chest Wall Nerve Block Continuous Infusion

Del Nido Versus HTK Cardioplegia in Adult Aortic Valve Replacement

Innovative Family Prevention With Latino Siblings in Disadvantaged Settings

Resiliency in Older Adults Undergoing Bone Marrow Transplant

Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections

EHR Precision Drug Treatment in Neonates

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center

Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer

SpHincterotomy for Acute Recurrent Pancreatitis

A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

CART22 Alone or in Combination With huCART19 for ALL

Dissemination of the Cardiovascular Risk Service

A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)

Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC

Metformin Therapy in Non-diabetic AAA Patients

Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)

Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma

Screening and Stimulation Testing for Residual Secretion of Adrenal Steroid Hormones in Autoimmune Addison's Disease

Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa

A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma

Development and Validation of a Language Screening Test in Acute Right Hemispheric Strokes

Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix

The Impact of Age-dependent Haptoglobin Deficiency on Plasma Free Hemoglobin Levels During Extracorporeal Membrane Oxygenation Support

Identification of Genetic Causes of Calcific Aortic Valve Disease

Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).

Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer

Cognition Evolution and MRI Markers in PPMS Patients on 2 Years

PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery

Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.

Oxandrolone Rotator Cuff Trial

Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease

PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study)

Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease

Negative Pressure Wound Therapy Compared to Traditional Care After Skin Grafting

Laser Vaginal Treatment for SUI

Reducing Lung CongestIon Symptoms in Advanced Heart Failure

Multidisciplinary Treatment of Chronic Vulvar Pain

ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis

Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer

Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Drug Combination (Rituximab Plus Gemcitabine and Oxaliplatin) for Relapsed/Refractory (That Has Come Back or Not Responded to Treatment) Transformed Diffuse Large B-Cell Lymphoma

Tight Versus Liberal Blood Glucose Control in Adult Critically Ill Patients

Pilot Study of the Liver Live Donor Champion Program

Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS